pregnancy management	290
evaluations can include:	50
evaluations include:	9
mothertobaby	5
evaluations can include the following:	5
use of antiepileptic medication during pregnancy reduces this risk	4
search clinicaltrials	3
see mothertobaby for further information on medication use during pregnancy	3
org	3
therapies under investigation	2
other	2
males	2
females	2
molecular genetic testing	2
identification of at-risk relatives	2
early determination of the genetic status of males at risk	2
determination of genetic status of females at risk	2
obstetric issues	2
newborn males	2
cys282tyr	2
particularly important are:	2
240 (170)	2
a parent, sib, or child	2
first-degree relatives share about half of their genes	2
a first cousin, great-grandparent, or great-grandchild	2
during pregnancy	2
see www	2
monitoring for these possible complications is recommended	1
the characteristic urinary steroid profile:	1
significantly elevated metabolites associated with:	1
fertility may be a concern	1
no reports describe reproduction in individuals with pord	1
hepatic drug metabolism	1
the common pathogenic variant p	1
stress should be minimized by providing good analgesia	1
urinalysis	1
a single urinalysis is sufficient in a male	1
relatives who have the family-specific pathogenic variant should:	1
undergo alps-specific evaluations at initial diagnosis (e	1
, lymphoma) become apparent (see surveillance)	1
severe dyslipidemia	1
and hyperglycemia	1
intensive multidisciplinary surveillance of any pregnancy would be mandatory	1
leu167del variant	1
if the apoe p	1
a woman with the apoe p	1
they are usually identified during family screening	1
plasma quantitative amino acid analysis	1
analysis of enzymatic activity in red blood cells	1
all pregnancies had a good outcome	1
peripartum intensive monitoring is advised	1
medication-associated risks to the fetus	1
, a beta-blocker) prior to conception	1
ecg, with consideration of signal-averaged electrocardiogram	1
echocardiogram	1
holter monitoring	1
cardiac mri	1
however, prenatal physiotherapy may be indicated	1
affected women should continue biotin and thiamine therapy during pregnancy	1
an optimal prenatal dose has not been determined	1
pregnancy may increase the risk of diabetic decompensation	1
for an affected mother	1
no pregnancy manaagement issues are known	1
for an affected child	1
no special management is required during pregnancy	1
pregnant females with classic 21-ohd cah	1
polyhydramnios	1
the cause of polyhydramnios is unknown	1
macrosomia	1
molecular genetic testing for the causative contiguous gene deletion	1
otologic examination and audiologic assessment	1
0 mg im, folic acid 5	1
of the 16 women, hemorrhage occured in ten	1
6% compared with 1	1
see malignant hyperthermia susceptibility for more details	1
deterioration during pregnancy may precipitate preterm delivery	1
mode of delivery is based on usual obstetric indications	1
data regarding teratogenicity of itraconazole are limited	1
the infants were normal	1
early diagnosis of relatives (i	1
completely asymptomatic individuals need not be tested	1
no issues are known	1
however, experience is limited	1
females with ciss may conceive normally	1
no complications during pregnancy have been reported to date	1
the prescription of clonidine should not be discontinued abruptly	1
data on pregnancies in cms are limited	1
trpv4-associated neuromuscular disorders	1
trpv4-associated skeletal dysplasias	1
no specific pregnancy management recommendations have been published	1
the symptoms of cmt can worsen during pregnancy	1
in particular: cramps, subjective sensitivity (e	1
, paresthesias), difficulty walking, and fatigue	1
no obvious effect has been observed	1
acute fatty liver of pregnancy	1
maternal liver disease	1
it is appropriate to evaluate relatives at risk (e	1
treatment with chenodeoxycholic acid should not be interrupted during pregnancy	1
otherwise serial ancs can be evaluated	1
other findings included:	1
dose adjustment may also be required post partum	1
pregnancy management for heterozygous females	1
, coronary artery disease)	1
, left ventricular enlargement but normal function	1
in most cases, pregnancy is contraindicated in dcm	1
evaluations may include:	1
consideration of other testing (e	1
during pregnancy the maternal hemoglobin level must be monitored	1
intrauterine growth retardation	1
preeclampsia	1
retroplacental hematoma	1
in utero fetal death	1
preterm delivery	1
telomere length testing	1
they should be followed closely by a perinatologist	1
recommendations vary by underlying genetic mechanism:	1
two women reported mild deterioration of dystonia	1
an increase in dose was required in one	1
see mothertobaby	1
org for further information on medication use during pregnancy	1
2-q13	1
caesarean section delivery may be required	1
labor and delivery may progress very rapidly	1
there is no clear advantage to vaginal vs	1
cesarean delivery	1
delivery should be performed in a medical center	1
pregnancy is not complicated by epp	1
there is no information on pregnancy management in xlp	1
measure α-gal a enzyme activity	1
however, the indications for family testing are unresolved	1
recommended genetic testing for at-risk family members	1
pregnancy/fertility/hormone use	1
visceral pain related to contractions during labor is perceived normally	1
therefor, analgesia should be provided	1
this is especially important when the p	1
poncz & cohen 1996	1
min et al 2008	1
goldman, personal communication to author]	1
diagnostic evaluations can include:	1
molecular genetic testing for the familial gata1 pathogenic variant	1
effect of anticonvulsants on hormonal methods of birth control	1
effects of anticonvulsants on conception	1
effect of pregnancy on anticonvulsant metabolism	1
effect of pregnancy on maternal seizure control	1
renal anomalies	1
skeletal differences such as club foot and craniosynostosis	1
and umbilical and inguinal hernia	1
baseline ultrasound of liver and kidneys prior to pregnancy	1
consideration of referral to high-risk obstetrician	1
metabolic control should be followed closely throughout the pregnancy	1
abdominal ultrasound should be performed every six to 12 weeks	1
the effect of pregnancy on inducing acute attacks is unpredictable	1
in general, serious problems during pregnancy are unusual	1
if the female is symptomatic (i	1
range: 15%-50%)	1
the following strategy is appropriate:	1
perform iron studies (i	1
no guidelines exist	1
common practice is to withhold phlebotomy during pregnancy	1
coli sepsis and pulmonary edema	1
testing of populations at risk	1
cessation of prophylactic antimicrobials is often advised during pregnancy	1
ideally cancer screening exams would be planned around a pregnancy	1
hyperpyrexia and its potential complications, including febrile seizures	1
, first 28 days of life)	1
no monitoring is needed for:	1
8%) and preeclampsia (7	1
7%)	1
children because of their increased risk for anemia	1
measurement of ldl-c level	1
table 4	1
degree of relatedness to an affected individual	1
first degree 1	1
second degree 2	1
third degree 3	1
cholesterol levels	1
total cholesterol (ldl cholesterol) in mg/dl	1
age	1
<20	1
220 (155)	1
230 (165)	1
20-29	1
250 (180)	1
260 (185)	1
30-39	1
270 (190)	1
280 (200)	1
290 (210)	1
40+	1
290 (205)	1
300 (215)	1
310 (225)	1
statins are contraindicated during pregnancy	1
pharmacologic treatment	1
statins are contraindicated in pregnancy due to concerns for teratogenicity	1
nursing mothers should not take statins	1
ldl apheresis is also occasionally used	1
regarding other agents:	1
pcsk9 inhibitors	1
use during pregnancy has not been well studied	1
ezetimibe	1
use during human pregnancy has not been well studied	1
niacin	1
higher doses have been associated with toxicity	1
risks during delivery include cephalopelvic disproportion	1
pregnancy in women with parkinson disease is a rare event	1
see hereditary hemorrhagic telangiectasia, pregnancy management	1
see mothertobaby for more information on medication use during pregnancy	1
edema may be exacerbated during pregnancy	1
if the ptpn11, raf1,	1
some carrier females develop gout in later years	1
if the causal tgfbr1,	1
pregnancy can be dangerous for women with lds	1
it is appropriate to evaluate at-risk sibs during infancy	1
measurement of plasma triglyceride concentration	1
affected mother	1
affected fetus	1
0 cm	1
at a root dimension <5	1
0cm) before becoming pregnant	1
pregnant women who have mcad deficiency must avoid catabolism	1
for the purpose of early diagnosis and treatment	1
for the purpose of kidney donation	1
no pregnancy issues are particular to adtkd-umod	1
thus, no particular recommendations can be made	1
no prenatal or perinatal neurologic manifestations of mls are known	1
using genomic testing that will detect the 15q13	1
close monitoring for intrauterine growth retardation is warranted	1
using genomic testing that will detect the 1q21	1
3 microdeletion	1
infertility may preclude pregnancy in some affected individuals	1
men 2a	1
fmtc	1
men 2b	1
albumin-corrected calcium or ionized calcium for hyperparathyroidism	1
, cardiac and renal defects)	1
fetal monitoring should follow standard guidelines	1
continuous epidural analgesia is highly recommended for labor and delivery	1
therapies under investigations	1
ultrasound abnormalities are not present in all affected pregnancies	1
abnormal presentation of an affected fetus may complicate delivery	1
no information on pregnancy management and outcomes is available	1
penetrance rates, however, are not known	1
the post-partum period is dangerous for the mother	1
evaluation includes targeted molecular genetic testing for the fgfr3 c	1
749c>g pathogenic variant	1
evaluation for placenta previa	1
otherwise, monitor renal findings (i	1
additional testing is not indicated	1
the first pregnancy ended in miscarriage at 19 weeks	1
, pre-eclampsia)	1
no treatment for the condition is available	1
birth is usually normal and uncomplicated	1
fetal akinesia often causes congenital contractures	1
clonus persists after birth and is usually severe	1
absence of respiratory movement necessitates mechanical support at birth	1
if not, treatment can be withdrawn	1
, avoidance of unattended swimming)	1
see treatment of manifestations	1
possible those who would benefit from initiation of treatment	1
1994a, schwartz et al 1994b]	1
it is recommended that every five years, asymptomatic	1
standardized questionnaire to assess the presence of respiratory	1
symptoms	1
family members are considered to have a positive screening	1
evaluation (i	1
, to possibly have pulmonary fibrosis) if they	1
family members	1
radiologic and histopathologic abnormalities suggestive of possible	1
early interstitial lung disease	1
it is unknown if these findings would	1
become symptomatic fpf in the subjects	1
see genetic	1
genetic counseling purposes	1
if the epor pathogenic variant in the family is known	1
if no pathogenic variant has been identified in the family	1
asymptomatic individuals:	1
can be monitored periodically for renal function and urinary oxalate	1
should maintain adequate hydration and avoid high-oxalate foods	1
in addition:	1
for those with the pathogenic variant p	1
gly170arg or p	1
phe152ile, pyridoxine should be supplemented	1
, heterozygous for one hoga1 pathogenic variant)	1
adequate fluid intake should be maintained throughout the pregnancy	1
measurement of serum potassium concentration and blood pressure	1
early diagnosis and treatment	1
surveillance as outlined in surveillance	1
see related genetic counseling issues	1
presymptomatic diagnosis:	1
permits early detection and treatment of complications and associated disorders	1
reassures those found to be unaffected	1
the literature on pregnancy and pkd is limited	1
women with pah deficiency	1
preconception	1
assessment of early osteopenia risk	1
discontinuation of lnaa treatment	1
post partum	1
provide coordinated care in the post-partum period	1
spasticity generally does not change significantly with pregnancy	1
pregnancy is generally not complicated by f-pct	1
newer effective therapies may decrease the risk	1
and an audiology evaluation	1
see published guidelines/consensus statements	1
prophylactic anticoagulation during pregnancy:	1
is recommended for all women:	1
should be considered for:	1
all women received a course of postpartum anticoagulation	1
all asymptomatic homozygous women	1
prevention of pregnancy loss	1
trialregister	1
nl, ntr 3361)	1
studies suggesting that prophylactic anticoagulation improves pregnancy outcome:	1
5% and 15	1
other pregnancy complications	1
young or uncooperative children may require examination under anesthesia	1
recommended doses during pregnancy are 10 mg/kg/day	1
evaluation can be accomplished by:	1
pregnancy in affected women appears to be generally uncomplicated	1
that has documented lqts	1
in which evaluation for lqts has not been performed	1
or both of the following:	1
weight gain during pregnancy can further impair gait ataxia	1
affected women may be on medications (e	1
, antiepileptics) to control the symptoms of sca17	1
successful pregnancies have occurred in women with short syndrome	1
if present, diabetes mellitus is managed as appropriate	1
the following are appropriate:	1
clinical appraisal and lateral skull radiograph as indicated	1
no pregnancy complications have been reported	1
almost all develop thrombocytopenia during pregnancy	1
it can be addressed on three levels:	1
maternal	1
avoidance of emergency c-section for fetal distress	1
fetal	1
familial	1
org for more information on medication exposure during pregnancy	1
audiology	1
abr, dpoae	1
such test results need to be interpreted with caution	1
, vhl syndrome or other hereditary disorder)	1
during pregnancy, affected women may develop small new lesions	1
penetrance is complete (i	1
delayed, secondary postpartum bleeding may be a problem	1
wolfram syndrome	1
low-frequency sensorineural hearing loss (lfsnhl)	1
pregnancies in women with ws are high risk	1
zinc has been used effectively during pregnancy	1
org for more information on medication use during pregnancy	1
there are no other special recommendations for pregnancy management	1
regular monitoring with pregnancy tests is indicated	1
